T1	CHEM 13 21	aspirina
#1	AnnotatorNotes T1	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T2	PROC 28 38	prevención
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	DISO 42 61	fenómenos embólicos
#3	AnnotatorNotes T3	C0013922; Embolism; Pathologic Function | C1704212; Embolus; Finding
T4	ANAT 79 85	mitral
#4	AnnotatorNotes T4	C0026264; Mitral Valve; Body Part, Organ, or Organ Component | C1269004; Entire mitral valve; Body Part, Organ, or Organ Component
T5	DISO 90 108	fibrilación atrial
#5	AnnotatorNotes T5	C0004238; Atrial Fibrillation; Disease or Syndrome
T6	DISO 125 143	fibrilación atrial
#6	AnnotatorNotes T6	C0004238; Atrial Fibrillation; Disease or Syndrome
T7	DISO 247 249	TE
#7	AnnotatorNotes T7	C0040038; Thromboembolism; Pathologic Function
T8	DISO 163 197	enfermedad valvar mitral reumática
T9	ANAT 174 180	valvar
#8	AnnotatorNotes T9	C1305961; Entire heart valve; Body Part, Organ, or Organ Component | C0018826; Heart Valves; Body Part, Organ, or Organ Component
T10	ANAT 181 187	mitral
#9	AnnotatorNotes T10	C0026264; Mitral Valve; Body Part, Organ, or Organ Component | C1269004; Entire mitral valve; Body Part, Organ, or Organ Component
T11	DISO 68 85	valvopatía mitral
#10	AnnotatorNotes T11	C0026265; Diseases of mitral valve; Disease or Syndrome
T12	DISO 230 245	tromboembolismo
#11	AnnotatorNotes T12	C0040038; Thromboembolism; Pathologic Function
T13	CHEM 275 285	medicación
#12	AnnotatorNotes T13	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T14	PROC 347 366	control terapéutico
T15	CHEM 406 414	Aspirina
#13	AnnotatorNotes T15	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T16	PROC 441 451	prevención
#14	AnnotatorNotes T16	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T17	CHEM 672 681	Varfarina
#15	AnnotatorNotes T17	C0043031; warfarin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T18	PROC 497 508	Controlamos
#16	AnnotatorNotes T18	C0030695; Patient Monitoring; Health Care Activity | C0150369; Preventive monitoring; Health Care Activity
T19	DISO 544 546	FA
#17	AnnotatorNotes T19	C0004238; Atrial Fibrillation; Disease or Syndrome
T20	PROC 558 591	estudio prospectivo y randomizado
#18	AnnotatorNotes T20	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T21	CHEM 612 620	Aspirina
#19	AnnotatorNotes T21	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T22	PROC 379 399	Comparar la eficacia
#20	AnnotatorNotes T22	C1707887; Efficacy Study; Research Activity
T23	DISO 776 793	eventos embólicos
#21	AnnotatorNotes T23	C0013922; Embolism; Pathologic Function | C1704212; Embolus; Finding
T24	DISO 1161 1214	nivel sérico de colesterol y triglicéridos aumentados
#22	AnnotatorNotes T24	C2712905; Elevated cholesterol with elevated triglycerides; Disease or Syndrome [ICD-10: E78.2]
T25	PROC 854 857	INR
#23	AnnotatorNotes T25	C0525032; International Normalized Ratio; Laboratory Procedure
T26	PROC 907 910	INR
#24	AnnotatorNotes T26	C0525032; International Normalized Ratio; Laboratory Procedure
T27	DISO 944 961	eventos embólicos
#25	AnnotatorNotes T27	C0013922; Embolism; Pathologic Function | C1704212; Embolus; Finding
T28	DISO 1489 1491	TE
#26	AnnotatorNotes T28	C0040038; Thromboembolism; Pathologic Function
T29	DISO 1061 1070	sangrados
#27	AnnotatorNotes T29	C0019080; Hemorrhage; Pathologic Function
T30	DISO 1105 1114	sangrados
#28	AnnotatorNotes T30	C0019080; Hemorrhage; Pathologic Function
T31	ANAT 1167 1173	sérico
#29	AnnotatorNotes T31	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T32	CHEM 1177 1187	colesterol
#30	AnnotatorNotes T32	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T33	DISO 1264 1287	eventos tromboembólicos
#31	AnnotatorNotes T33	C0040038; Thromboembolism; Pathologic Function
T34	CHEM 1663 1672	Varfarina
#32	AnnotatorNotes T34	C0043031; warfarin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T35	DISO 1414 1421	embolia
#33	AnnotatorNotes T35	C0013922; Embolism; Pathologic Function | C1704212; Embolus; Finding
T36	CHEM 1433 1441	Aspirina
#34	AnnotatorNotes T36	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T37	PROC 1474 1484	prevención
#35	AnnotatorNotes T37	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T38	DISO 1514 1531	valvopatía mitral
#36	AnnotatorNotes T38	C0026265; Diseases of mitral valve; Disease or Syndrome
T39	ANAT 1525 1531	mitral
#37	AnnotatorNotes T39	C0026264; Mitral Valve; Body Part, Organ, or Organ Component | C1269004; Entire mitral valve; Body Part, Organ, or Organ Component
T40	DISO 1550 1570	insuficiencia mitral
#38	AnnotatorNotes T40	C0026266; Mitral Valve Insufficiency; Pathologic Function
T41	ANAT 1592 1598	mitral
#39	AnnotatorNotes T41	C0026264; Mitral Valve; Body Part, Organ, or Organ Component | C1269004; Entire mitral valve; Body Part, Organ, or Organ Component
T42	CHEM 1677 1685	Aspirina
#40	AnnotatorNotes T42	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T43	PROC 1720 1730	prevención
#41	AnnotatorNotes T43	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T44	ANAT 102 108	atrial
#42	AnnotatorNotes T44	C0018792; Heart Atrium; Body Part, Organ, or Organ Component
T45	ANAT 137 143	atrial
#43	AnnotatorNotes T45	C0018792; Heart Atrium; Body Part, Organ, or Organ Component
T46	DISO 145 147	FA
#44	AnnotatorNotes T46	C0004238; Atrial Fibrillation; Disease or Syndrome
T47	DISO 476 478	FA
#45	AnnotatorNotes T47	C0004238; Atrial Fibrillation; Disease or Syndrome
T48	DISO 1735 1737	TE
#46	AnnotatorNotes T48	C0040038; Thromboembolism; Pathologic Function
T49	PROC 1019 1030	tratamiento
#47	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	CHEM 1190 1203	triglicéridos
#48	AnnotatorNotes T50	C0041004; Triglycerides; Biologically Active Substance · Organic Chemical
T51	DISO 1384 1386	FA
#49	AnnotatorNotes T51	C0004238; Atrial Fibrillation; Disease or Syndrome
T52	ANAT 1564 1570	mitral
#50	AnnotatorNotes T52	C0026264; Mitral Valve; Body Part, Organ, or Organ Component | C1269004; Entire mitral valve; Body Part, Organ, or Organ Component
T53	PROC 1573 1598	prótesis biológica mitral
T54	CHEM 1 10	Varfarina
#51	AnnotatorNotes T54	C0043031; warfarin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T55	CHEM 262 271	Varfarina
#52	AnnotatorNotes T55	C0043031; warfarin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T56	CHEM 425 434	Varfarina
#53	AnnotatorNotes T56	C0043031; warfarin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T57	DISO 456 458	TE
#54	AnnotatorNotes T57	C0040038; Thromboembolism; Pathologic Function
T58	LIVB 462 471	pacientes
#55	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 513 522	pacientes
#56	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Dose 621 627	200 mg
T61	Frequency 627 631	/día
T62	Neg_cue 878 888	excluyendo
T63	LIVB 893 902	pacientes
#57	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Neg_cue 1053 1055	No
T68	Date 1387 1407	hace menos de un año
T69	Neg_cue 1410 1413	sin
T70	DEVI 1573 1591	prótesis biológica
T74	LIVB 1294 1303	población
#58	AnnotatorNotes T74	C1257890; Population; Population Group
T75	PROC 686 702	dosis ajustables
#59	AnnotatorNotes T75	C2826232; Dose Adjustment; Health Care Activity
T65	LIVB 524 527	pts
#60	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	LIVB 597 600	pts
#61	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	Observation 330 338	adhesión
#62	AnnotatorNotes T67	C2364172; Adherence To Medication Regime; Finding
T71	Result_or_Value 911 921	inadecuado
#63	AnnotatorNotes T71	C0205412; Inadequate (qualifier); Qualitative Concept
T72	Observation 1007 1030	adhesión al tratamiento
#64	AnnotatorNotes T72	C2364172; Adherence To Medication Regime; Finding
T73	Neg_cue 1315 1317	no
T76	CONC 1327 1337	diferencia
#65	AnnotatorNotes T76	C1705241; Delta (difference); Quantitative Concept
T77	Observation 1226 1242	factor de riesgo
#66	AnnotatorNotes T77	C0035648; risk factors; Finding
T78	Observation 1642 1657	baja adherencia
#67	AnnotatorNotes T78	C0032646; Poor compliance; Finding
A1	Assertion T29 Negated
A4	Assertion T35 Negated
A2	Assertion T63 Negated
A6	Status T35 History_of
A3	Assertion T34 Contraindicated
R1	Used_for Arg1:T1 Arg2:T2
R2	Used_for Arg1:T54 Arg2:T2
R3	Location_of Arg1:T4 Arg2:T11
R4	Location_of Arg1:T44 Arg2:T5
R5	Overlap Arg1:T11 Arg2:T5
R7	Overlap Arg1:T6 Arg2:T8
R8	Location_of Arg1:T10 Arg2:T8
R9	Location_of Arg1:T45 Arg2:T6
R10	Location_of Arg1:T45 Arg2:T46
R11	Overlap Arg1:T46 Arg2:T8
R12	Causes Arg1:T6 Arg2:T12
R13	Causes Arg1:T46 Arg2:T12
R14	Causes Arg1:T46 Arg2:T7
R15	Causes Arg1:T6 Arg2:T7
R16	Used_for Arg1:T55 Arg2:T14
R17	Used_for Arg1:T15 Arg2:T16
R18	Used_for Arg1:T56 Arg2:T16
R19	Experiences Arg1:T58 Arg2:T57
R20	Experiences Arg1:T58 Arg2:T47
R21	Experiences Arg1:T58 Arg2:T56
R22	Experiences Arg1:T58 Arg2:T15
R23	Experiences Arg1:T59 Arg2:T18
R24	Experiences Arg1:T65 Arg2:T18
R25	Experiences Arg1:T65 Arg2:T19
R26	Experiences Arg1:T59 Arg2:T19
R27	Experiences Arg1:T66 Arg2:T21
R28	Has_Dose_or_Strength Arg1:T21 Arg2:T60
R29	Has_Frequency Arg1:T21 Arg2:T61
R30	Used_for Arg1:T17 Arg2:T75
R31	Experiences Arg1:T66 Arg2:T75
R32	Negation Arg1:T62 Arg2:T63
R33	Experiences Arg1:T63 Arg2:T26
R34	Has_Result_or_Value Arg1:T26 Arg2:T71
R35	Experiences Arg1:T63 Arg2:T27
R36	Negation Arg1:T64 Arg2:T29
R37	Experiences Arg1:T74 Arg2:T33
R38	Experiences Arg1:T74 Arg2:T24
R39	Negation Arg1:T73 Arg2:T76
A5	Assertion T76 Negated
R40	Location_of Arg1:T31 Arg2:T24
R41	Experiences Arg1:T74 Arg2:T77
R42	Before Arg1:T24 Arg2:T33
R43	Overlap Arg1:T51 Arg2:T68
R44	Negation Arg1:T69 Arg2:T35
R45	Used_for Arg1:T36 Arg2:T37
R47	Location_of Arg1:T39 Arg2:T38
R48	Location_of Arg1:T52 Arg2:T40
R49	Used_for Arg1:T70 Arg2:T53
R50	Location_of Arg1:T41 Arg2:T53
R51	Used_for Arg1:T42 Arg2:T43
T80	Quantifier_or_Qualifier 1071 1078	mayores
A7	Assertion T80 Negated
R53	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T80	
T81	Quantifier_or_Qualifier 1096 1104	Pequeños
R54	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T81	
R55	Used_for Arg1:T34 Arg2:T43	
R56	Before Arg1:T2 Arg2:T3	
R6	Before Arg1:T16 Arg2:T57	
R46	Before Arg1:T43 Arg2:T48	
#68	AnnotatorNotes T80	C0205164; Major; Qualitative Concept
R52	Negation Arg1:T64 Arg2:T80	
#69	AnnotatorNotes T81	C0205165; Minor (value); Qualitative Concept
R57	Before Arg1:T37 Arg2:T28	
#70	AnnotatorNotes T8	C0264765; Rheumatic disease of mitral valve; Disease or Syndrome
A8	Experiencer T58 Patient
A9	Experiencer T65 Patient
A10	Experiencer T59 Patient
A11	Experiencer T66 Patient
A12	Experiencer T63 Patient
A13	Experiencer T74 Patient
A14	Assertion T78 Hypothetical
